< (From left) Dr. Cindy Pricilia, Ph.D. Candidate Cheon Woo Moon, Distinguished Professor Sang Yup Lee > Currently, the world is suffering from environmental problems caused by plastic waste. The KAIST research team has succeeded in producing a microbial-based plastic that is biodegradable and can replace existing PET bottles, making it a hot topic. Our university announced on the 7th of November that the research team of Distinguished Professor Sang Yup Lee of the Department of Ch
2024-11-08< Photos from KAIST-POSTECH Science War (photographed by Student Junhyeok Park of KAIST Freshman Course) > The future leaders of science at KAIST and POSTECH (President Seong Keun Kim) held their annual science and sporting event at POSTECH for two days from September 20th to 21st. The 'KAIST-POSTECH Science War (hereafter KA-PO War)' is a festival consisting of science and sports games and various side events to promote exchange and cooperation between the two universities. It is als
2024-09-19A team of researchers published a paper on developing a substitute for eggs using microorganisms, grabbing international attention. It is expected that the development of egg substitutes using non-animal raw materials will solve the problems of factory farming, which causes problems like increased emission of greenhouse gas and waste, and contribute to building a sustainable food system that allows easy protein intake. KAIST (President Kwang-Hyung Lee) announced that Research Professor Kyeong R
2024-07-05< (From left) KAIST President Kwang-Hyung Lee and Merck CEO Matthias Heinzel > KAIST (President Kwang-Hyung Lee) signed a Memorandum of Understanding (MOU) with Merck Life Science (CEO Matthias Heinzel) on May 29 to foster innovation and technology creation in advanced biotechnology. Since May of last year, the two institutions have been discussing multidimensional innovation programs and will now focus on industry-academia cooperation to tackle bioindustry challenges with this MOU a
2024-05-30A team of Korean researchers have succeeded in developing a new drug candidate for the treatment of non-alcoholic fatty liver disease (NAFLD) acting on peripheral tissues. To date, there has not been an optimal treatment for non-alcoholic steatohepatitis (NASH), and this discovery is expected to set the grounds for the development of new drugs that can safely suppress both liver fat accumulation and liver fibrosis at the same time. A joint research team led by Professor Jin Hee Ahn from Gwang
2024-02-21